Stone Ridge Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-4,480
| Closed | -$1.02M | – | 498 |
|
2020
Q2 | $1.02M | Sell |
4,480
-1,514
| -25% | -$344K | 0.16% | 105 |
|
2020
Q1 | $913K | Sell |
5,994
-2,600
| -30% | -$396K | 0.1% | 227 |
|
2019
Q4 | $1.29M | Buy |
8,594
+900
| +12% | +$135K | 0.08% | 326 |
|
2019
Q3 | $1.09M | Buy |
7,694
+1,700
| +28% | +$241K | 0.07% | 378 |
|
2019
Q2 | $750K | Hold |
5,994
| – | – | 0.04% | 534 |
|
2019
Q1 | $661K | Sell |
5,994
-4,700
| -44% | -$518K | 0.04% | 602 |
|
2018
Q4 | $1.05M | Hold |
10,694
| – | – | 0.06% | 396 |
|
2018
Q3 | $1.32M | Hold |
10,694
| – | – | 0.07% | 337 |
|
2018
Q2 | $1.06M | Buy |
10,694
+404
| +4% | +$40.1K | 0.06% | 389 |
|
2018
Q1 | $909K | Buy |
10,290
+1,000
| +11% | +$88.3K | 0.05% | 435 |
|
2017
Q4 | $917K | Buy |
+9,290
| New | +$917K | 0.06% | 430 |
|